These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3075839)

  • 1. New concepts of the growth spurt of puberty.
    Stanhope R; Preece MA; Grant DB; Brook CG
    Acta Paediatr Scand Suppl; 1988; 347():30-7. PubMed ID: 3075839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GH/IGF-I axis in puberty.
    Loche S; Casini MR; Faedda A
    Br J Clin Pract Suppl; 1996 Aug; 85():1-4. PubMed ID: 8995016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
    Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue.
    Carel JC
    Mol Cell Endocrinol; 2006 Jul; 254-255():226-33. PubMed ID: 16787697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced growth hormone secretion prolongs puberty but does not delay the developmental increase in luteinizing hormone in the absence of gonadal negative feedback.
    Wilson ME; Chikazawa K; Fisher J; Mook D; Gould KG
    Biol Reprod; 2004 Aug; 71(2):588-97. PubMed ID: 15115727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue.
    Stanhope R; Pringle PJ; Brook CG
    Acta Paediatr Scand; 1988 Jul; 77(4):525-30. PubMed ID: 3293348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV; Khadilkar VV; Maskati GB
    Indian Pediatr; 2005 Jan; 42(1):57-60. PubMed ID: 15695861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [True precocious puberty in non-tumor hydrocephalus. An analysis of 16 cases].
    Brauner R; Rappaport R; Nicod C; Malandry F; Thibaud E; Pierre-Kahn A; Renier D; Sainte-Rose C; Hirsch JF
    Arch Fr Pediatr; 1987; 44(6):433-6. PubMed ID: 3304186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of puberty in growth hormone deficient children.
    Saggese G; Federico G; Barsanti S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():329-34. PubMed ID: 10698597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH and GHBP activity and not IGF-1 and its receptor activity express growth velocity reduction during treatment of central precocious puberty by a superactive GNRH analogue.
    Eshet R; Silbergeld A; Kauli R; Lazar L; Laron Z
    Isr J Med Sci; 1994 Aug; 30(8):592-5. PubMed ID: 8045738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The somatotropic axis in puberty.
    Brook CG; Hindmarsh PC
    Endocrinol Metab Clin North Am; 1992 Dec; 21(4):767-82. PubMed ID: 1486875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK; Fan X; Tang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pubertal growth and growth hormone secretion.
    Martha PM; Reiter EO
    Endocrinol Metab Clin North Am; 1991 Mar; 20(1):165-82. PubMed ID: 2029886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mid-growth spurt--a pre-puberty growth spurt. Review of its significance and biological correlations].
    Mühl A; Herkner KR; Swoboda W
    Padiatr Padol; 1992; 27(5):119-23. PubMed ID: 1437227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.